Back to 
Zürcher Kantonalbank
Zürcher Kantonalbank
KPTI
Showing 0 of 22 quarters
Position history for Zürcher Kantonalbank's holdings in Karyopharm Therapeutics Inc.
No. Zürcher Kantonalbank exited its KPTI (Karyopharm Therapeutics) position in Q2 2024. Its Q1 2024 13F listed 6 shares worth $9. Zürcher Kantonalbank already held KPTI in its Q1 2019 13F, the earliest on record, and held it in 21 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.